The Scientist2y
Harboring Hard and Soft Cells Lets Tumors Grow and Metastasize Simultaneously
Tumors are notorious for being harder than normal tissue, making them possible to identify through palpation. However, scientists who study individual cancer cells have found that the cells are ...
Physician's Weekly1d
Prognostic Factors and Treatment Outcomes in Dedifferentiated Liposarcoma
The following is a summary of "Clinical course and prognostic factors of patients with dedifferentiated liposarcoma: a ...
technologynetworks1mon
Genetic Changes Alone Cannot Explain Tumor Growth in NF-1 Patients
Despite what was previously thought, new research has shown that genetic changes alone cannot explain why and where tumours grow in those with genetic condition neurofibromatosis type 1 (NF-1).
The Globe and Mail27d
Soft Tissue Sarcoma Market on Track for Major Expansion by 2032, According to DelveInsight | Moleculin Biotech
The Key Soft Tissue Sarcoma Companies in the market include - Advenchen Laboratories, Philogen, Gradalis, Epizyme, Chugai Pharma France, CytRx, Taiho Pharmaceuticals, KaryoPharm Therapeutics ...
SynOx Therapeutics Announces Board Chair Transition to Align with Advancing Regulatory and Commercialization Strategy
Strengthened Leadership and Expanded U.S. Presence Positions SynOx for Regulatory Filings and Commercialization of Emactuzumab for Tenosynovial Giant Cell Tumours (TGCT) DUBLIN, Ireland and OXFORD, ...